108 related articles for article (PubMed ID: 18776722)
1. Effects of dietary conjugated linoleic acid in advanced experimental polycystic kidney disease.
Scatliff CE; Bankovic-Calic N; Ogborn MR; Aukema HM
Nephron Exp Nephrol; 2008; 110(2):e44-8. PubMed ID: 18776722
[TBL] [Abstract][Full Text] [Related]
2. Dietary conjugated linoleic acid reduces PGE2 release and interstitial injury in rat polycystic kidney disease.
Ogborn MR; Nitschmann E; Bankovic-Calic N; Weiler HA; Fitzpatrick-Wong S; Aukema HM
Kidney Int; 2003 Oct; 64(4):1214-21. PubMed ID: 12969139
[TBL] [Abstract][Full Text] [Related]
3. Late dietary intervention limits benefits of soy protein or flax oil in experimental polycystic kidney disease.
Sankaran D; Bankovic-Calic N; Cahill L; Yu-Chen Peng C; Ogborn MR; Aukema HM
Nephron Exp Nephrol; 2007; 106(4):e122-8. PubMed ID: 17622740
[TBL] [Abstract][Full Text] [Related]
4. Dietary soy protein effects on disease and IGF-I in male and female Han:SPRD-cy rats.
Aukema HM; Housini I
Kidney Int; 2001 Jan; 59(1):52-61. PubMed ID: 11135057
[TBL] [Abstract][Full Text] [Related]
5. Dietary conjugated linoleic acid renal benefits and possible toxicity vary with isomer, dose and gender in rat polycystic kidney disease.
Ogborn MR; Nitschmann E; Goldberg A; Bankovic-Calic N; Weiler HA; Aukema HM
Lipids; 2008 Sep; 43(9):783-91. PubMed ID: 18629561
[TBL] [Abstract][Full Text] [Related]
6. [Effect of a modified low protein and low fat diet on histologic changes and metabolism in kidneys in an experimental model of polycystic kidney disease].
Banković-Calić N; Ogbori MR; Nicman E
Srp Arh Celok Lek; 2002; 130(7-8):251-7. PubMed ID: 12585002
[TBL] [Abstract][Full Text] [Related]
7. A dietary conjugated linoleic acid treatment that slows renal disease progression alters renal cyclooxygenase-2-derived prostanoids in the Han: SPRD-cy rat.
Wakefield AP; Ogborn MR; Ibrahim N; Aukema HM
J Nutr Biochem; 2012 Aug; 23(8):908-14. PubMed ID: 21940154
[TBL] [Abstract][Full Text] [Related]
8. Conjugated linoleic acid reduces parathyroid hormone in health and in polycystic kidney disease in rats.
Weiler H; Austin S; Fitzpatrick-Wong S; Nitschmann E; Bankovic-Calic N; Mollard R; Aukema H; Ogborn M
Am J Clin Nutr; 2004 Jun; 79(6 Suppl):1186S-1189S. PubMed ID: 15159255
[TBL] [Abstract][Full Text] [Related]
9. Detrimental effects of a high fat diet in early renal injury are ameliorated by fish oil in Han:SPRD-cy rats.
Lu J; Bankovic-Calic N; Ogborn M; Saboorian MH; Aukema HM
J Nutr; 2003 Jan; 133(1):180-6. PubMed ID: 12514287
[TBL] [Abstract][Full Text] [Related]
10. Renal cyclooxygenase and lipoxygenase products are altered in polycystic kidneys and by dietary soy protein and fish oil treatment in the Han:SPRD-Cy rat.
Ibrahim NH; Jia Y; Devassy JG; Yamaguchi T; Aukema HM
Mol Nutr Food Res; 2014 Apr; 58(4):768-81. PubMed ID: 24170691
[TBL] [Abstract][Full Text] [Related]
11. Effects of flaxseed derivatives in experimental polycystic kidney disease vary with animal gender.
Ogborn MR; Nitschmann E; Bankovic-Calic N; Weiler HA; Aukema HM
Lipids; 2006 Dec; 41(12):1141-9. PubMed ID: 17269560
[TBL] [Abstract][Full Text] [Related]
12. Modification of polycystic kidney disease and fatty acid status by soy protein diet.
Ogborn MR; Nitschmann E; Weiler HA; Bankovic-Calic N
Kidney Int; 2000 Jan; 57(1):159-66. PubMed ID: 10620197
[TBL] [Abstract][Full Text] [Related]
13. The effect of paclitaxel on the progression of polycystic kidney disease in rodents.
Martinez JR; Cowley BD; Gattone VH; Nagao S; Yamaguchi T; Kaneta S; Takahashi H; Grantham JJ
Am J Kidney Dis; 1997 Mar; 29(3):435-44. PubMed ID: 9041221
[TBL] [Abstract][Full Text] [Related]
14. A new in vitro bioassay for cyst formation by renal cells from an autosomal dominant rat model of polycystic kidney disease.
Pey R; Bach J; Schieren G; Gretz N; Hafner M
In Vitro Cell Dev Biol Anim; 1999; 35(10):571-9. PubMed ID: 10614866
[TBL] [Abstract][Full Text] [Related]
15. High dietary fat intake increases renal cyst disease progression in Han:SPRD-cy rats.
Jayapalan S; Saboorian MH; Edmunds JW; Aukema HM
J Nutr; 2000 Sep; 130(9):2356-60. PubMed ID: 10958835
[TBL] [Abstract][Full Text] [Related]
16. Caspase inhibition reduces tubular apoptosis and proliferation and slows disease progression in polycystic kidney disease.
Tao Y; Kim J; Faubel S; Wu JC; Falk SA; Schrier RW; Edelstein CL
Proc Natl Acad Sci U S A; 2005 May; 102(19):6954-9. PubMed ID: 15863619
[TBL] [Abstract][Full Text] [Related]
17. Targeting of sodium-glucose cotransporters with phlorizin inhibits polycystic kidney disease progression in Han:SPRD rats.
Wang X; Zhang S; Liu Y; Spichtig D; Kapoor S; Koepsell H; Mohebbi N; Segerer S; Serra AL; Rodriguez D; Devuyst O; Mei C; Wüthrich RP
Kidney Int; 2013 Nov; 84(5):962-8. PubMed ID: 23715121
[TBL] [Abstract][Full Text] [Related]
18. Amelioration of polycystic kidney disease by modification of dietary protein intake in the rat.
Ogborn MR; Sareen S
J Am Soc Nephrol; 1995 Dec; 6(6):1649-54. PubMed ID: 8749693
[TBL] [Abstract][Full Text] [Related]
19. Effect of lovastatin on the development of polycystic kidney disease in the Han:SPRD rat.
Gile RD; Cowley BD; Gattone VH; O'Donnell MP; Swan SK; Grantham JJ
Am J Kidney Dis; 1995 Sep; 26(3):501-7. PubMed ID: 7645559
[TBL] [Abstract][Full Text] [Related]
20. Trans-10,cis-12-conjugated linoleic acid worsens renal pathology and alters cyclooxygenase derived oxylipins in obesity-associated nephropathy.
Zhan Y; Shi H; Caligiuri SP; Wu Y; Declercq V; Taylor CG; Zahradka P; Ogborn MR; Aukema HM
J Nutr Biochem; 2015 Feb; 26(2):130-7. PubMed ID: 25458529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
